{"id":19355,"date":"2026-06-02T14:42:49","date_gmt":"2026-06-02T17:42:49","guid":{"rendered":"https:\/\/fenati.org.br\/?p=19355"},"modified":"2026-06-02T14:42:49","modified_gmt":"2026-06-02T17:42:49","slug":"nova-pilula-esperanca-pacientes-cancer-de-pancreas","status":"publish","type":"post","link":"https:\/\/homolog.fenati.org.br\/en\/nova-pilula-esperanca-pacientes-cancer-de-pancreas\/","title":{"rendered":"Nova p\u00edlula d\u00e1 esperan\u00e7a a pacientes com c\u00e2ncer de p\u00e2ncreas avan\u00e7ado"},"content":{"rendered":"<p><strong>C\u00e2ncer de p\u00e2ncreas &#8211;<\/strong> Um novo tratamento oral para c\u00e2ncer de p\u00e2ncreas metast\u00e1tico chamou a aten\u00e7\u00e3o da comunidade m\u00e9dica internacional ap\u00f3s apresentar resultados considerados hist\u00f3ricos em um dos principais eventos de oncologia do mundo. Os dados finais do estudo cl\u00ednico envolvendo o medicamento daraxonrasib foram recebidos com forte repercuss\u00e3o entre especialistas e podem representar uma mudan\u00e7a importante no tratamento da doen\u00e7a.<\/p>\n<p>O estudo avaliou 500 pacientes com c\u00e2ncer de p\u00e2ncreas avan\u00e7ado que j\u00e1 n\u00e3o respondiam \u00e0 <a href=\"https:\/\/pt.wikipedia.org\/wiki\/Quimioterapia\">quimioterapia<\/a>. Os participantes foram divididos aleatoriamente em dois grupos: um recebeu o comprimido experimental e o outro continuou com o tratamento convencional. O modelo adotado \u00e9 considerado um dos mais rigorosos da pesquisa cl\u00ednica, utilizado para verificar a efic\u00e1cia real de novos medicamentos.<\/p>\n<p><a href=\"https:\/\/fenati.org.br\/brasil-propria-netflix-gratuita-tecnologia-nacional\/\"><strong>LEIA: Brasil faz sua pr\u00f3pria \u2018Netflix\u2019 gratuita com tecnologia nacional<\/strong><\/a><\/p>\n<p>Os resultados mostraram um aumento expressivo na sobrevida dos pacientes tratados com o daraxonrasib. Entre aqueles que apresentavam a muta\u00e7\u00e3o RAS G12, a mais frequente nesse tipo de c\u00e2ncer, a sobrevida mediana chegou a 13,2 meses, enquanto no grupo tratado com quimioterapia foi de 6,6 meses. O risco de morte tamb\u00e9m apresentou redu\u00e7\u00e3o significativa.<\/p>\n<p>O medicamento demonstrou ainda ganhos no controle da progress\u00e3o da doen\u00e7a. O tempo at\u00e9 o avan\u00e7o do c\u00e2ncer foi superior ao observado com a quimioterapia, al\u00e9m de apresentar taxas mais elevadas de redu\u00e7\u00e3o do tamanho dos tumores.<\/p>\n<p>Outro aspecto que chamou a aten\u00e7\u00e3o dos pesquisadores foi o perfil de seguran\u00e7a do tratamento. Apenas uma pequena parcela dos pacientes precisou interromper o uso do medicamento devido a efeitos colaterais, \u00edndice consideravelmente menor do que o registrado entre aqueles que receberam quimioterapia.<\/p>\n<p>Os pesquisadores conclu\u00edram que o daraxonrasib tem potencial para se tornar o novo padr\u00e3o de tratamento para pacientes com c\u00e2ncer de p\u00e2ncreas metast\u00e1tico que j\u00e1 passaram pela terapia convencional sem sucesso.<\/p>\n<p>A relev\u00e2ncia dos resultados est\u00e1 diretamente ligada \u00e0 dificuldade hist\u00f3rica de tratar esse tipo de tumor. O c\u00e2ncer de p\u00e2ncreas costuma ser diagnosticado em est\u00e1gios avan\u00e7ados, quando as possibilidades terap\u00eauticas j\u00e1 s\u00e3o mais limitadas. Al\u00e9m disso, a doen\u00e7a apresenta alta resist\u00eancia aos tratamentos dispon\u00edveis.<\/p>\n<p>Parte desse desafio est\u00e1 relacionada \u00e0s altera\u00e7\u00f5es na prote\u00edna RAS, presente na maioria dos tumores pancre\u00e1ticos. Durante d\u00e9cadas, cientistas buscaram formas de bloquear sua a\u00e7\u00e3o, mas encontraram dificuldades devido \u00e0s caracter\u00edsticas da mol\u00e9cula. O daraxonrasib foi desenvolvido justamente para atuar sobre esse mecanismo, alcan\u00e7ando resultados que por muito tempo pareciam fora de alcance.<\/p>\n<p>Com a conclus\u00e3o do estudo, a pr\u00f3xima etapa ser\u00e1 a an\u00e1lise regulat\u00f3ria. A empresa respons\u00e1vel pelo medicamento informou que pretende solicitar autoriza\u00e7\u00e3o para comercializa\u00e7\u00e3o junto \u00e0s autoridades de sa\u00fade dos Estados Unidos.<\/p>\n<p><em><strong>(Com informa\u00e7\u00f5es de g1)<\/strong><\/em><br \/>\n<em><strong>(Foto: Reprodu\u00e7\u00e3o\/Magnific\/atlascompany)<\/strong><\/em><\/p>","protected":false},"excerpt":{"rendered":"<p>Estudo com 500 pacientes mostrou aumento significativo da sobrevida e menor taxa de efeitos colaterais em compara\u00e7\u00e3o \u00e0 quimioterapia convencional<\/p>","protected":false},"author":11,"featured_media":19357,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[42],"tags":[13],"class_list":["post-19355","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-noticias","tag-sindical"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Nova p\u00edlula d\u00e1 esperan\u00e7a a pacientes com c\u00e2ncer de p\u00e2ncreas avan\u00e7ado - FENATI<\/title>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nova p\u00edlula d\u00e1 esperan\u00e7a a pacientes com c\u00e2ncer de p\u00e2ncreas avan\u00e7ado - FENATI\" \/>\n<meta property=\"og:description\" content=\"Estudo com 500 pacientes mostrou aumento significativo da sobrevida e menor taxa de efeitos colaterais em compara\u00e7\u00e3o \u00e0 quimioterapia convencional\" \/>\n<meta property=\"og:url\" content=\"https:\/\/homolog.fenati.org.br\/en\/nova-pilula-esperanca-pacientes-cancer-de-pancreas\/\" \/>\n<meta property=\"og:site_name\" content=\"FENATI\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/feittinf\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-02T17:42:49+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/homolog.fenati.org.br\/wp-content\/uploads\/2026\/06\/design-sem-nome-2026-06-02t143911669.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"630\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Caio Simidzu\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@FederacaoTiBR\" \/>\n<meta name=\"twitter:site\" content=\"@FederacaoTiBR\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Caio Simidzu\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/homolog.fenati.org.br\\\/nova-pilula-esperanca-pacientes-cancer-de-pancreas\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/homolog.fenati.org.br\\\/nova-pilula-esperanca-pacientes-cancer-de-pancreas\\\/\"},\"author\":{\"name\":\"Caio Simidzu\",\"@id\":\"https:\\\/\\\/homolog.fenati.org.br\\\/#\\\/schema\\\/person\\\/966badfad0bf2512a372e082dc1c783e\"},\"headline\":\"Nova p\u00edlula d\u00e1 esperan\u00e7a a pacientes com c\u00e2ncer de p\u00e2ncreas avan\u00e7ado\",\"datePublished\":\"2026-06-02T17:42:49+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/homolog.fenati.org.br\\\/nova-pilula-esperanca-pacientes-cancer-de-pancreas\\\/\"},\"wordCount\":508,\"publisher\":{\"@id\":\"https:\\\/\\\/homolog.fenati.org.br\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/homolog.fenati.org.br\\\/nova-pilula-esperanca-pacientes-cancer-de-pancreas\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/homolog.fenati.org.br\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/design-sem-nome-2026-06-02t143911669.jpg\",\"keywords\":[\"sindical\"],\"articleSection\":[\"Not\u00edcias\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/homolog.fenati.org.br\\\/nova-pilula-esperanca-pacientes-cancer-de-pancreas\\\/\",\"url\":\"https:\\\/\\\/homolog.fenati.org.br\\\/nova-pilula-esperanca-pacientes-cancer-de-pancreas\\\/\",\"name\":\"Nova p\u00edlula d\u00e1 esperan\u00e7a a pacientes com c\u00e2ncer de p\u00e2ncreas avan\u00e7ado - FENATI\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/homolog.fenati.org.br\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/homolog.fenati.org.br\\\/nova-pilula-esperanca-pacientes-cancer-de-pancreas\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/homolog.fenati.org.br\\\/nova-pilula-esperanca-pacientes-cancer-de-pancreas\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/homolog.fenati.org.br\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/design-sem-nome-2026-06-02t143911669.jpg\",\"datePublished\":\"2026-06-02T17:42:49+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/homolog.fenati.org.br\\\/nova-pilula-esperanca-pacientes-cancer-de-pancreas\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/homolog.fenati.org.br\\\/nova-pilula-esperanca-pacientes-cancer-de-pancreas\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/homolog.fenati.org.br\\\/nova-pilula-esperanca-pacientes-cancer-de-pancreas\\\/#primaryimage\",\"url\":\"https:\\\/\\\/homolog.fenati.org.br\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/design-sem-nome-2026-06-02t143911669.jpg\",\"contentUrl\":\"https:\\\/\\\/homolog.fenati.org.br\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/design-sem-nome-2026-06-02t143911669.jpg\",\"width\":1200,\"height\":630,\"caption\":\"C\u00e2ncer de p\u00e2ncreas avan\u00e7ado tem possibilidade de tratamento tratamento a partir de p\u00edlula (Foto: Reprodu\u00e7\u00e3o\\\/Magnific\\\/atlascompany)\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/homolog.fenati.org.br\\\/nova-pilula-esperanca-pacientes-cancer-de-pancreas\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\\\/\\\/homolog.fenati.org.br\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nova p\u00edlula d\u00e1 esperan\u00e7a a pacientes com c\u00e2ncer de p\u00e2ncreas avan\u00e7ado\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/homolog.fenati.org.br\\\/#website\",\"url\":\"https:\\\/\\\/homolog.fenati.org.br\\\/\",\"name\":\"FEITTINF\",\"description\":\"Federa\u00e7\u00e3o Nacional dos Trabalhadores em Tecnologia da\u00a0Informa\u00e7\u00e3o\",\"publisher\":{\"@id\":\"https:\\\/\\\/homolog.fenati.org.br\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/homolog.fenati.org.br\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/homolog.fenati.org.br\\\/#organization\",\"name\":\"FEITTINF\",\"url\":\"https:\\\/\\\/homolog.fenati.org.br\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/homolog.fenati.org.br\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/homolog.fenati.org.br\\\/wp-content\\\/uploads\\\/2023\\\/08\\\/logo_300x50.png\",\"contentUrl\":\"https:\\\/\\\/homolog.fenati.org.br\\\/wp-content\\\/uploads\\\/2023\\\/08\\\/logo_300x50.png\",\"width\":350,\"height\":50,\"caption\":\"FEITTINF\"},\"image\":{\"@id\":\"https:\\\/\\\/homolog.fenati.org.br\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/feittinf\",\"https:\\\/\\\/x.com\\\/FederacaoTiBR\",\"https:\\\/\\\/www.instagram.com\\\/feittinf\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/homolog.fenati.org.br\\\/#\\\/schema\\\/person\\\/966badfad0bf2512a372e082dc1c783e\",\"name\":\"Caio Simidzu\",\"url\":\"https:\\\/\\\/homolog.fenati.org.br\\\/en\\\/author\\\/caio-simidzu\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nova p\u00edlula d\u00e1 esperan\u00e7a a pacientes com c\u00e2ncer de p\u00e2ncreas avan\u00e7ado - FENATI","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"Nova p\u00edlula d\u00e1 esperan\u00e7a a pacientes com c\u00e2ncer de p\u00e2ncreas avan\u00e7ado - FENATI","og_description":"Estudo com 500 pacientes mostrou aumento significativo da sobrevida e menor taxa de efeitos colaterais em compara\u00e7\u00e3o \u00e0 quimioterapia convencional","og_url":"https:\/\/homolog.fenati.org.br\/en\/nova-pilula-esperanca-pacientes-cancer-de-pancreas\/","og_site_name":"FENATI","article_publisher":"https:\/\/www.facebook.com\/feittinf","article_published_time":"2026-06-02T17:42:49+00:00","og_image":[{"width":1200,"height":630,"url":"https:\/\/homolog.fenati.org.br\/wp-content\/uploads\/2026\/06\/design-sem-nome-2026-06-02t143911669.jpg","type":"image\/jpeg"}],"author":"Caio Simidzu","twitter_card":"summary_large_image","twitter_creator":"@FederacaoTiBR","twitter_site":"@FederacaoTiBR","twitter_misc":{"Written by":"Caio Simidzu","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/homolog.fenati.org.br\/nova-pilula-esperanca-pacientes-cancer-de-pancreas\/#article","isPartOf":{"@id":"https:\/\/homolog.fenati.org.br\/nova-pilula-esperanca-pacientes-cancer-de-pancreas\/"},"author":{"name":"Caio Simidzu","@id":"https:\/\/homolog.fenati.org.br\/#\/schema\/person\/966badfad0bf2512a372e082dc1c783e"},"headline":"Nova p\u00edlula d\u00e1 esperan\u00e7a a pacientes com c\u00e2ncer de p\u00e2ncreas avan\u00e7ado","datePublished":"2026-06-02T17:42:49+00:00","mainEntityOfPage":{"@id":"https:\/\/homolog.fenati.org.br\/nova-pilula-esperanca-pacientes-cancer-de-pancreas\/"},"wordCount":508,"publisher":{"@id":"https:\/\/homolog.fenati.org.br\/#organization"},"image":{"@id":"https:\/\/homolog.fenati.org.br\/nova-pilula-esperanca-pacientes-cancer-de-pancreas\/#primaryimage"},"thumbnailUrl":"https:\/\/homolog.fenati.org.br\/wp-content\/uploads\/2026\/06\/design-sem-nome-2026-06-02t143911669.jpg","keywords":["sindical"],"articleSection":["Not\u00edcias"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/homolog.fenati.org.br\/nova-pilula-esperanca-pacientes-cancer-de-pancreas\/","url":"https:\/\/homolog.fenati.org.br\/nova-pilula-esperanca-pacientes-cancer-de-pancreas\/","name":"Nova p\u00edlula d\u00e1 esperan\u00e7a a pacientes com c\u00e2ncer de p\u00e2ncreas avan\u00e7ado - FENATI","isPartOf":{"@id":"https:\/\/homolog.fenati.org.br\/#website"},"primaryImageOfPage":{"@id":"https:\/\/homolog.fenati.org.br\/nova-pilula-esperanca-pacientes-cancer-de-pancreas\/#primaryimage"},"image":{"@id":"https:\/\/homolog.fenati.org.br\/nova-pilula-esperanca-pacientes-cancer-de-pancreas\/#primaryimage"},"thumbnailUrl":"https:\/\/homolog.fenati.org.br\/wp-content\/uploads\/2026\/06\/design-sem-nome-2026-06-02t143911669.jpg","datePublished":"2026-06-02T17:42:49+00:00","breadcrumb":{"@id":"https:\/\/homolog.fenati.org.br\/nova-pilula-esperanca-pacientes-cancer-de-pancreas\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/homolog.fenati.org.br\/nova-pilula-esperanca-pacientes-cancer-de-pancreas\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/homolog.fenati.org.br\/nova-pilula-esperanca-pacientes-cancer-de-pancreas\/#primaryimage","url":"https:\/\/homolog.fenati.org.br\/wp-content\/uploads\/2026\/06\/design-sem-nome-2026-06-02t143911669.jpg","contentUrl":"https:\/\/homolog.fenati.org.br\/wp-content\/uploads\/2026\/06\/design-sem-nome-2026-06-02t143911669.jpg","width":1200,"height":630,"caption":"C\u00e2ncer de p\u00e2ncreas avan\u00e7ado tem possibilidade de tratamento tratamento a partir de p\u00edlula (Foto: Reprodu\u00e7\u00e3o\/Magnific\/atlascompany)"},{"@type":"BreadcrumbList","@id":"https:\/\/homolog.fenati.org.br\/nova-pilula-esperanca-pacientes-cancer-de-pancreas\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/homolog.fenati.org.br\/"},{"@type":"ListItem","position":2,"name":"Nova p\u00edlula d\u00e1 esperan\u00e7a a pacientes com c\u00e2ncer de p\u00e2ncreas avan\u00e7ado"}]},{"@type":"WebSite","@id":"https:\/\/homolog.fenati.org.br\/#website","url":"https:\/\/homolog.fenati.org.br\/","name":"FEITTINF","description":"Federa\u00e7\u00e3o Nacional dos Trabalhadores em Tecnologia da\u00a0Informa\u00e7\u00e3o","publisher":{"@id":"https:\/\/homolog.fenati.org.br\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/homolog.fenati.org.br\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/homolog.fenati.org.br\/#organization","name":"FEITTINF","url":"https:\/\/homolog.fenati.org.br\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/homolog.fenati.org.br\/#\/schema\/logo\/image\/","url":"https:\/\/homolog.fenati.org.br\/wp-content\/uploads\/2023\/08\/logo_300x50.png","contentUrl":"https:\/\/homolog.fenati.org.br\/wp-content\/uploads\/2023\/08\/logo_300x50.png","width":350,"height":50,"caption":"FEITTINF"},"image":{"@id":"https:\/\/homolog.fenati.org.br\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/feittinf","https:\/\/x.com\/FederacaoTiBR","https:\/\/www.instagram.com\/feittinf\/"]},{"@type":"Person","@id":"https:\/\/homolog.fenati.org.br\/#\/schema\/person\/966badfad0bf2512a372e082dc1c783e","name":"Caio Simidzu","url":"https:\/\/homolog.fenati.org.br\/en\/author\/caio-simidzu\/"}]}},"_links":{"self":[{"href":"https:\/\/homolog.fenati.org.br\/en\/wp-json\/wp\/v2\/posts\/19355","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/homolog.fenati.org.br\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/homolog.fenati.org.br\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/homolog.fenati.org.br\/en\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/homolog.fenati.org.br\/en\/wp-json\/wp\/v2\/comments?post=19355"}],"version-history":[{"count":1,"href":"https:\/\/homolog.fenati.org.br\/en\/wp-json\/wp\/v2\/posts\/19355\/revisions"}],"predecessor-version":[{"id":19358,"href":"https:\/\/homolog.fenati.org.br\/en\/wp-json\/wp\/v2\/posts\/19355\/revisions\/19358"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/homolog.fenati.org.br\/en\/wp-json\/wp\/v2\/media\/19357"}],"wp:attachment":[{"href":"https:\/\/homolog.fenati.org.br\/en\/wp-json\/wp\/v2\/media?parent=19355"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/homolog.fenati.org.br\/en\/wp-json\/wp\/v2\/categories?post=19355"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/homolog.fenati.org.br\/en\/wp-json\/wp\/v2\/tags?post=19355"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}